Brexit | The RSA Group

Providing leadership for the life sciences industry

Our Services
Our Teams
Why we are Different
Talent Matters
News & Views
Candidates
Contact Us

Recent posts

What’s the Outlook for MedTech in 2019? Key Challenges and Opportunities
March 7, 2019
Making the leap into self-employment? Don't be an interim lemming
February 28, 2019
Anyone for T?
February 12, 2019
JPM 2019 |The fundamentals remain strong despite the doubters
January 23, 2019
Launching your first medical product in Europe? How not to fail at the first step.
November 23, 2018

Follow us

The RSA Blog
The RSA Group on LinkedIn
The RSA Group on Twitter
The RSA Group on YouTube

Popular tags

Better Hiring Big Data Big Pharma Bioinformatics Biotech Boards Brexit Cancer CEO Choice Consultant Consumer Health CRO CSO Deloitte's Digital Healthcare Diversity Due Diligence Freelancer Global market Healthcare HTA Immuno-oncology Interims IP JP Morgan Leadership Life Sciences M&A Maximise Success Medical Affairs medtech Med Tech Oral Health Partner People Pharma Preclinical Proof of Candidate R&D Regulatory Shortlist Singapore SMEs Strategic Thinking Supply Chain Talent Talent Equity TOPRA Valuation

View Archives »

Spotlight On

Read the report Catch up on RSA's blog: Talent Matters

The latest RSA News

Placement | CEO, Clasado
RSA Viewpoint | 2019 Outlook
Mark Johnson joins The RSA Group as Partner
RSA Viewpoint | Why we should stop talking about Diversity & Inclusion Initiatives
Placement | Non-Executive Director, Consilient Health

The RSA Blog
The RSA Group on LinkedIn
The RSA Group on Twitter
The RSA Group on YouTube

RSA Consulting Limited
Registered office: Thomas House, 84 Eccleston Square, London SW1V 1PX
Registered in England: company registration number 1803896

Website: Terms of use | Privacy policy | Cookie policy

Design by jcreative.co.uk

This website uses cookies to improve your experience. Accept Read More